查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1317804

连续皮下胰岛素输注市场：副产品（贴片帮浦、繫绳帮浦）、病患类型（1 型糖尿病、2 型糖尿病）和最终用户 - 2023-2030 年全球预测

Continuous Subcutaneous Insulin Infusion Market by Product (Patch Pumps, Tethered Pumps), Patient Type (Type 1 Diabetes, Type 2 Diabetes), End-user - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球持续皮下胰岛素输注市场预计到2023年将达到27.2398亿美元，年复合成长率为12.14%，预计到2030年将出现惊人的增长，达到60.8372亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球连续皮下胰岛素输注市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.持续皮下胰岛素输注的全球市场规模与预测为何？

2.在预测期内，COVID-19 对全球连续皮下胰岛素输注市场的阻碍因素与影响有哪些？

3.在预测期内，全球连续皮下胰岛素输注市场需要投资哪些产品/细分市场/应用/领域？

4.全球持续皮下胰岛素输注市场的竞争策略为何？

5. 全球持续皮下胰岛素输注市场的技术趋势和法律规范是什么？

6.全球连续皮下胰岛素输注市场主要供应商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球持续皮下胰岛素输注市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的糖尿病患者数量正在增加
      • 人们对先进胰岛素输送设备的认识不断增强
      • 全球与糖尿病相关的医疗费用增加
    • 抑制因素
      • 设备成本高
    • 机会
      • 人工智慧和物联网等新技术的进步
      • 市场相关人员推出的产品数量持续增加
    • 任务
      • 可能的风险，如糖尿病酮酸症和低血糖
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章连续皮下胰岛素输注市场：副产品

  • 贴片泵浦
    • 基本
    • 基础和丸剂
    • 老闆
  • 繫绳帮浦
    • 电池
    • 胰岛素储液器和药筒
    • 胰岛素套插入装置

第7章依病患类型分類的连续皮下胰岛素输注市场

  • 1型糖尿病
  • 2型糖尿病

第8章连续皮下胰岛素输注市场：依最终用户分类

  • 居家护理
  • 医院
  • 实验室

第9章美洲连续皮下胰岛素输注市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太连续皮下胰岛素输注市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲连续皮下胰岛素输注市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-A339DAEFA76A

The Global Continuous Subcutaneous Insulin Infusion Market is forecasted to grow significantly, with a projected USD 2,723.98 million in 2023 at a CAGR of 12.14% and expected to reach a staggering USD 6,083.72 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Continuous Subcutaneous Insulin Infusion Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Continuous Subcutaneous Insulin Infusion Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Patch Pumps and Tethered Pumps. The Patch Pumps is further studied across Basal, Basal & Bolus, and Bous. The Tethered Pumps is further studied across Battery, Insulin Reservoir & Cartridges, and Insulin Set Insertion Devices. The Patch Pumps is projected to witness significant market share during forecast period.

Based on Patient Type, market is studied across Type 1 Diabetes and Type 2 Diabetes. The Type 1 Diabetes is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Homecare, Hospitals, and Laboratory. The Homecare is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Continuous Subcutaneous Insulin Infusion Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Continuous Subcutaneous Insulin Infusion Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Continuous Subcutaneous Insulin Infusion Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Continuous Subcutaneous Insulin Infusion Market?

4. What is the competitive strategic window for opportunities in the Global Continuous Subcutaneous Insulin Infusion Market?

5. What are the technology trends and regulatory frameworks in the Global Continuous Subcutaneous Insulin Infusion Market?

6. What is the market share of the leading vendors in the Global Continuous Subcutaneous Insulin Infusion Market?

7. What modes and strategic moves are considered suitable for entering the Global Continuous Subcutaneous Insulin Infusion Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Continuous Subcutaneous Insulin Infusion Market, by Product, 2022 vs 2030
  • 4.3. Continuous Subcutaneous Insulin Infusion Market, by Patient Type, 2022 vs 2030
  • 4.4. Continuous Subcutaneous Insulin Infusion Market, by End-user, 2022 vs 2030
  • 4.5. Continuous Subcutaneous Insulin Infusion Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of diabetes patients across the world
      • 5.1.1.2. Growing awareness of advanced insulin delivery devices
      • 5.1.1.3. Rising healthcare expenditure pertinent to diabetes globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technological advancements such as AI and IoT
      • 5.1.3.2. Ongoing rise in the number of product launches by market players
    • 5.1.4. Challenges
      • 5.1.4.1. Possible risks such as diabetic ketoacidosis and hypoglycemia
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Continuous Subcutaneous Insulin Infusion Market, by Product

  • 6.1. Introduction
  • 6.2. Patch Pumps
    • 6.2.1. Basal
    • 6.2.2. Basal & Bolus
    • 6.2.3. Bous
  • 6.3. Tethered Pumps
    • 6.3.1. Battery
    • 6.3.2. Insulin Reservoir & Cartridges
    • 6.3.3. Insulin Set Insertion Devices

7. Continuous Subcutaneous Insulin Infusion Market, by Patient Type

  • 7.1. Introduction
  • 7.2. Type 1 Diabetes
  • 7.3. Type 2 Diabetes

8. Continuous Subcutaneous Insulin Infusion Market, by End-user

  • 8.1. Introduction
  • 8.2. Homecare
  • 8.3. Hospitals
  • 8.4. Laboratory

9. Americas Continuous Subcutaneous Insulin Infusion Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Continuous Subcutaneous Insulin Infusion Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Continuous Subcutaneous Insulin Infusion Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2022 VS 2030 (%)
  • FIGURE 6. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET DYNAMICS
  • FIGURE 9. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 6. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL & BOLUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 11. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BATTERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN RESERVOIR & CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN SET INSERTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 232. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 233. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET LICENSE & PRICING